Prostatype Genomics AB
PROGEN | FN
Overview
Corporate Details
- ISIN(s):
- SE0022574554 (+2 more)
- LEI:
- 549300JO6MPCGPVHVU91
- Country:
- Sweden
- Address:
- Gustav III:s Boulevard 34, 169 73 Solna
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Prostatype Genomics AB offers genomic testing for prostate cancer diagnostics. Their tests support personalized treatment decisions.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1750064205&Signature=FCVyXe~hSDtqckXD0kvAMxT5oJZgjBE0Z-xfGpR8aojk-MQvcEOppIezpPPp6KZtOHcQvnA32LMgeoEPd~A8cFGb3tS7gRIA3u4uXBamNq8H~8~FP2MCe-j0rFASOFrazXUkmwjGBbXwCI~AjPoGgHxj1Rg2lUAgQfg~VLHlRd93woJrnYBkeTS5F~91kR-l4WIc7ZAZYqos4ulrkjw7~4ufQ~c7wNh4IcpYYZKtqhppb5PP-lmSoyDRmMBN72Qg~54f~pecaBs5vk03crnAht5hzopZY3tr4tI3cPBVpzwrF05KggcGrwZS8JWrhos9HmiQHdesUQvCXicGUO1VrQ__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |